UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 327

Sortiert nach

Search for risk genes in schizophrenia

Nervenarzt, 2017-07, Vol.88 (7), p.751-754

Rujescu, D

2017

Volltextzugriff (PDF)

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

Acta psychiatrica Scandinavica, 2019-01, Vol.139 (1), p.78-88

2019

Volltextzugriff (PDF)

S.26.02 Genomics research in suicidology

European neuropsychopharmacology, 2015-09, Vol.25, p.S148-S149

Rujescu, D

2015

Volltextzugriff (PDF)

Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci

Molecular psychiatry, 2014-01, Vol.19 (1), p.41-49

2014

Volltextzugriff (PDF)

The European Psychiatric Association (EPA) guidance on suicide treatment and prevention

European psychiatry, 2012-02, Vol.27 (2), p.129-141

2012

Volltextzugriff (PDF)

Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years

Molecular psychiatry, 2021-10, Vol.26 (10), p.5812-5822

2021

Volltextzugriff (PDF)

Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients

Molecular psychiatry, 2015-02, Vol.20 (2), p.150-151

2015

Volltextzugriff (PDF)

Silexan for treatment of psychiatric manifestations in the context of COVID-19: a case series

European psychiatry, 2023-03, Vol.66 (S1), p.S798-S799

2023

Volltextzugriff (PDF)

The HLA 8.1 ancestral haplotype in schizophrenia: dual implication in neuro‐synaptic pruning and autoimmunity?

Acta psychiatrica Scandinavica, 2020-02, Vol.141 (2), p.169-171

2020

Volltextzugriff (PDF)

Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research

Schizophrenia bulletin, 2015-05, Vol.41 (3), p.574-583

2015

Volltextzugriff (PDF)

Neurexin 1 (NRXN1) Deletions in Schizophrenia

Schizophrenia bulletin, 2009-09, Vol.35 (5), p.851-854

2009

Volltextzugriff (PDF)

Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia

Molecular psychiatry, 2017-10, Vol.22 (10), p.1502-1508

2017

Volltextzugriff (PDF)

Elevated cytokine expression in the orbitofrontal cortex of victims of suicide

Acta psychiatrica Scandinavica, 2008-03, Vol.117 (3), p.198-206

2008

Volltextzugriff (PDF)

Analysis of genetic diversity in patients with major psychiatric disorders versus healthy controls: A molecular-genetic study of 1698 subjects genotyped for 100 candidate genes (549 SNPs)

Psychiatry research, 2024-03, Vol.333, p.115720-115720, Article 115720

2024

Volltextzugriff (PDF)

Suche nach Risikogenen bei Schizophrenie

Nervenarzt, 2017-07, Vol.88 (7), p.751-754

Rujescu, D.

2017

Volltextzugriff (PDF)

Comparison of etomidate and methohexital as anesthetic agents for continuation and maintenance electroconvulsive therapy: A retrospective analysis of seizure quality and safety

Journal of affective disorders, 2023-06, Vol.330, p.33-39

2023

Volltextzugriff (PDF)

AS23-02 - How important are rare genetic variants in psychiatric disorders? experiences from schizophrenia, autism, and bipolar disorder research

European psychiatry, 2012, Vol.27, p.1-1

Rujescu, D

2012

Volltextzugriff (PDF)

Correction: Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years

Molecular psychiatry, 2021-10, Vol.26 (10), p.5823-5823

2021

Volltextzugriff (PDF)

The promise of biological markers for treatment response in first-episode psychosis: a systematic review

Schizophrenia bulletin, 2015-05, Vol.41 (3), p.559-573

2015

Volltextzugriff (PDF)

Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET

Molecular psychiatry, 2021-03, Vol.26 (3), p.1009-1018

2021

Volltextzugriff (PDF)

S.01.02 Metabolomics: how to better diagnose and understand drug response in schizophrenia

European neuropsychopharmacology, 2011, Vol.21, p.S185-S185

Rujescu, D

2011

Volltextzugriff (PDF)

Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder

Molecular psychiatry, 2011-04, Vol.16 (4), p.429-441

2011

Volltextzugriff (PDF)

High loading of polygenic risk in cases with chronic schizophrenia

Molecular psychiatry, 2016-07, Vol.21 (7), p.969-974

2016

Volltextzugriff (PDF)

The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics

Schizophrenia bulletin, 2015-05, Vol.41 (3), p.549-558

2015

Volltextzugriff (PDF)

Instability of personal human metabotype is linked to all-cause mortality

Scientific reports, 2018-06, Vol.8 (1), p.9810-10, Article 9810

2018

Volltextzugriff (PDF)

1 – 25 von 327

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTranslational Psychiatry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(314)
Mit Volltextzugriff
(283)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Psychiatry
(137)
Life Sciences & Biomedicine
(134)
Humans
(132)
Male
(71)
Female
(70)
Neurosciences & Neurology
(69)
Neurosciences
(66)
Adult
(60)
Schizophrenia
(55)
Middle Aged
(46)
Biological And Medical Sciences
(45)
Medical Sciences
(44)
Biochemistry & Molecular Biology
(41)
Medicin Och Hälsovetenskap
(40)
Schizophrenia - Genetics
(40)
Genotype
(38)
Psychology. Psychoanalysis. Psychiatry
(38)
Case-Control Studies
(37)
Genomes
(37)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Search for risk genes in schizophrenia

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

S.26.02 Genomics research in suicidology

Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci

The European Psychiatric Association (EPA) guidance on suicide treatment and prevention

Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years

Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients

Silexan for treatment of psychiatric manifestations in the context of COVID-19: a case series

The HLA 8.1 ancestral haplotype in schizophrenia: dual implication in neuro‐synaptic pruning and autoimmunity?

Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research

Neurexin 1 (NRXN1) Deletions in Schizophrenia

Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia

Elevated cytokine expression in the orbitofrontal cortex of victims of suicide

Analysis of genetic diversity in patients with major psychiatric disorders versus healthy controls: A molecular-genetic study of 1698 subjects genotyped for 100 candidate genes (549 SNPs)

Suche nach Risikogenen bei Schizophrenie

Comparison of etomidate and methohexital as anesthetic agents for continuation and maintenance electroconvulsive therapy: A retrospective analysis of seizure quality and safety

AS23-02 - How important are rare genetic variants in psychiatric disorders? experiences from schizophrenia, autism, and bipolar disorder research

Correction: Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years

The promise of biological markers for treatment response in first-episode psychosis: a systematic review

Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET

S.01.02 Metabolomics: how to better diagnose and understand drug response in schizophrenia

Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder

High loading of polygenic risk in cases with chronic schizophrenia

The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics

Instability of personal human metabotype is linked to all-cause mortality

Aktive Filter

Suchergebnisse filtern